!

, , , ,
.

(Dexketoprofen), ,
, 25
101, 103, 105,
()
1
100% 36,9,
25

( -?)

(Dexketoprofen),
,

, 25 101, 103,
105, ()

25 (Dexketoprofen), ,
, 25 101, 103,
105, - /
()
KVR/TAB-FMK 05.08.2015 .
():
04080, . , . ,63

,
10.07.2014, /
220020, ,
. , . , 1031412
.:+375 17 236 40 50; +375 17 236 40 51
: +375 17 236 40 52
-mail: v@marketico.by; amelina@marketico.by

.

.
,
PGG2 PGH2,
PGE1, PGE2, PGF2,

PGD2, PGI2 2
2. ,
,
,
.

-1 -2
.
. ,

,
30 4-6 .


30 (15-60 ).

0,35 1,65 .

(99
%)

0,25 /.


.
S-(+), R(+)- .
,

,
,
.

, max ,
( tmax).

(Dexketoprofen),
, , 25,
()

25
(Dexketoprofen),

-
/ ()

1. 1865 .
2. .
3.

4.
5.
6.
7.
8.

/
.
1 ,
.
.
40 (
) 4 .

.

.

(Exclusion criteria):
1.

.
2.

.
3. / ,
, .
4.
.
.
5. -
,
.
6. .
7.
.
8. ,
(
), ,
,
.
9. ,

.
10.

.
11.
30
.
1.
.
2.

,
.
3.
,
.

4.

.
5.
/ ,
.

, ..

.

.

(
)

() .

8
(SPID 08).

8
(PID max).

.

, ,
, 50% 4 6
25 . 47% (129 225
).
, , 50%
4 6 .
15% (38 248 ).

/
.
24 (72)

:
:

t-
;

U-

;

.
() :

(
), 95%
;

(
) 95% ;

95%
.

(
-).

-,
..

p<0,05
80%.


.

.
,
, , 1842009 (02040)
.
ICH-GCP ( 1842009 (02040) )

(, 2004).

10.

:
1. , ,
:
n=( Z+Z )2( P ( 1P ) )2 /D 2
2. , :
n=( Z+Z )22 Sx 2 /2
: n , ;
Z = 1,96;
Z = 0,84; D ; P
; ;Sx
;


(
15 ).
20 %,
0,82 [1, 2].
,
30 .
60
. 80%,
. 60
80%,
.
, ,

.

.
,
.
,
.
,
( ),
, . -
,
.
, 0.
- (
,
),
. .
, ..
, .
.
,
,
.

-.
. ,
, ,
. ,
, ,
.
,
( ) . ()
/ .

.
:
(t- )
;
(U- )
;
( )
;

 ( )
.
() :
( );
( );

.
() :

2 .

,
.
.
p<0,05. (1)
80%.

1. Ryan Thomas P., Sample Size Determination and Power. John Wiley & Sons,
Inc., 2013, p. 378.
2. Chow Shein-Chung, Wang Hansheng, Shao Jun. Sample Size Calculations in
Clinical Research. 2nd ed., Chapman &Hall/CRC, 2007, p. 359.
3. Walters Stephen J. Sample size and power estimation for studies with health
related quality of life outcomes: a comparison of four methods using the SF36. Health and Quality of Life Outcomes 2004, 2:26.
4. Lwanga S.K., Lemeshow S. Sample size determination in health studies. WHO,
1991, p. 80.